Regencell Bioscience Holdings (RGC) Net Shares Issued and Repurchased (2023 - 2025)
Regencell Bioscience Holdings' (RGC) quarterly Net Shares Issued and Repurchased came in at $4.8 million in Q2 2025, up 2623.35% quarter-over-quarter from $175326.0 in Q2 2023.
Powered by 
Analysis
Regencell Bioscience Holdings (RGC) Net Shares Issued and Repurchased (2023 - 2025) Analysis & Trends
Regencell Bioscience Holdings (RGC) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $4.8 million the latest figure, recorded in Q2 2025.
- For the quarter ending Q2 2025, Net Shares Issued and Repurchased changed N/A year-over-year to $4.8 million; the trailing twelve-month figure through Jun 2025 stood at $4.8 million (changed N/A YoY), and the FY2025 full-year result was $4.8 million, changed N/A from the prior year.
- Net Shares Issued and Repurchased rose to $4.8 million in Q2 2025 per RGC's latest filing, from $175326.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $4.8 million in Q2 2025 and bottomed at $175326.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | - |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | - |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | Regencell Bioscience Holdings | 75.87 Mn | 73.51 Mn | - | - |